Clinical Psychology and Psychiatry: A Closer Look

Psychiatric medications, science, marketing, psychiatry in general, and occasionally clinical psychology. Questioning the role of key opinion leaders and the use of "science" to promote commercial ends rather than the needs of people with mental health concerns.

Friday, October 31, 2008

You Really Can Report Safety Data

›
A new study concluded that the combination of sertraline (Zoloft) and cognitive-behavioral therapy (CBT) worked better than either treatment...
8 comments:
Monday, October 27, 2008

Psychiatric Diagnoses: Fact or Fiction?

›
Below is a guest post from Tim Desmond. I do not necessarily agree with all of the the contents of the post below, but I thought the topic w...
14 comments:
Saturday, October 18, 2008

The Latest on Kiddie Bipolar

›
A recent study in the Archives of General Psychiatry claimed that kiddie bipolar tends to become adult bipolar. I have read the study and ...
8 comments:
Friday, October 10, 2008

APA Membership Rejects Torture

›
APA Membership Rejects Torture The American Psychological Association membership recently overrode their leadership (the Council of Represen...
2 comments:
Monday, October 06, 2008

A Month in The Life of Chuck "High Life" Nemeroff

›
The psychiatry world is belatedly exhibiting outrage toward a man whose ability to lure pharma cash seems to know no bounds. He may be the ...
8 comments:
Friday, October 03, 2008

Uh-Oh Chuck, They Out To Get You, Man

›
According to the New York Times and Wall Street Journal , it looks like Charlie " Bling Bling " Nemeroff is under investigation b...
1 comment:
Wednesday, October 01, 2008

Prialt Pushed Through Duplicate Publication

›
Apparently, the same data on Elan's pain medication Prialt (ziconotide) was published twice. Same data set. No reference in the second...
Tuesday, September 30, 2008

Gabitril Goes Down

›
Gabitril (tiagabine) is an antiseizure medication from Cephalon, which just forked out a cool $425 million to settle charges that it market...
6 comments:
Thursday, September 25, 2008

The Cymbalta Schatz-Storm: Duplicate Publication and Lying by Omission

›
This post details the duplicate publication of data on the antidepressant duloxetine (Cymbalta). Marketing and "science" collide ...
15 comments:
Tuesday, September 23, 2008

Dear American

›
As for our latest economic crisis, I couldn't resist stealing this from Angry Bear : Dear American: I need to ask you to support an urge...
2 comments:

Doing Some Digging

›
Some good material is coming. Unfortunately, it involves the same old people doing the same old tricks. But the scandal factor is reasonab...
Thursday, September 18, 2008

Big Drugs, Small Brains?

›
I've read on and off about brain shrinkage being linked to antipsychotics. I have not paid a lot of attention to research on the topic ...
15 comments:
Monday, September 15, 2008

Bipolar Overawareness Week: New York Times Magazine Edition

›
Jennifer Egan has a roughly 29,000 word piece in the New York Times magazine regarding child bipolar disorder. OK, maybe it just seemed th...
9 comments:
Monday, September 08, 2008

Atypical Antipsychotics for All, Oregon Chapter

›
Oh boy. Here we go again. A study published online ahead of print at the Journal of Clinical Psychiatry notes that among Oregon Medicaid...
6 comments:
Friday, September 05, 2008

Not to Get Political or Anything

›
I write about all sorts of BS that relates to mental health treatment. Mostly about marketing infiltrating science. But hey, it's a fr...
Wednesday, September 03, 2008

That Pesky Long-Lasting Placebo

›
You are depressed, take a placebo, and feel better. Conventional wisdom in the psychiatric community would have your depression coming back...
12 comments:
Wednesday, August 27, 2008

The V-Squad Finale

›
Here is the final of the 3 training clips for Vioxx salespersons. The first and second clips are also available. Be The Power: 2 efficacy...
1 comment:
Tuesday, August 26, 2008

More From the V-Squad

›
The Superhero team of Merck sales reps continued to work hard to push Vioxx. The ending of this clip is definitely a cliffhanger, so be sur...
2 comments:
Monday, August 25, 2008

Meet the V-Squad

›
How did Merck go about training reps to sell Vioxx? Here's part one of three. Thanks to an anonymous reader for sending me along this ...
Tuesday, August 19, 2008

Investigative Journalism Par Excellence

›
I am a little late in reporting this story, but there is a must-read post from Jonathan Leo over at Chemical Imbalance that I must bring to...
5 comments:
‹
›
Home
View web version

About Me

CL Psych
I'm an academic with a respectable amount of clinical experience and no drug industry funding. Given my lack of time, don't expect multiple daily updates. Certain things about clinical psychology, the drug industry, psychiatry, and academics drive me nuts, and you'll probably pick up on these pet peeves before long...
View my complete profile
Powered by Blogger.